Arrowhead Pharmaceuticals’ Proprietary Pulmonary TRiM™ Platform Achieves High Levels of Target Gene Knockdown and Long Duration of Effect

Arrowhead Pharmaceuticals’ Proprietary Pulmonary TRiM ™ Platform Achieves High Levels of Target Gene Knockdown and Long Duration of Effect.

Scroll to Top